|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-10-23
|
|
pubmed:abstractText |
Therapeutic endpoints based on reduced clinical worsening represent clinically relevant and realistic goals for patients suffering from progressive neurodegenerative disorders such as Alzheimer's disease (AD).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9824
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2009 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
244-51
|
|
pubmed:dateRevised |
2011-11-3
|
|
pubmed:meshHeading |
pubmed-meshheading:19786776-Aged,
pubmed-meshheading:19786776-Aged, 80 and over,
pubmed-meshheading:19786776-Alzheimer Disease,
pubmed-meshheading:19786776-Disease Progression,
pubmed-meshheading:19786776-Double-Blind Method,
pubmed-meshheading:19786776-Female,
pubmed-meshheading:19786776-Humans,
pubmed-meshheading:19786776-Indans,
pubmed-meshheading:19786776-Male,
pubmed-meshheading:19786776-Middle Aged,
pubmed-meshheading:19786776-Neuropsychological Tests,
pubmed-meshheading:19786776-Nootropic Agents,
pubmed-meshheading:19786776-Odds Ratio,
pubmed-meshheading:19786776-Piperidines,
pubmed-meshheading:19786776-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease.
|
|
pubmed:affiliation |
Memory Assessment and Research Centre, Moorgreen Hospital, Southampton, UK. David.Wilkinson@hantspt-sw.nhs.uk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
